Scripps Research scientists have developed a machine-learning system-;a type of artificial intelligence (AI) application-;that can track the detailed evolution of epidemic viruses and predict the emergence of viral variants with important new properties.
Subcutaneous C5 Inhibitor Approved for PNH
The FDA approved the complement C5 inhibitor crovalimab (Piasky) for treating paroxysmal nocturnal hemoglobinuria (PNH), a rare but life-threatening blood disease. Indicated for PNH in
June 25, 2024